Becton, Dickinson and Company
BDX · NYSEBecton Dickinson reported FY2025 revenue of $21.84 billion and Q2 FY2026 revenue of $4.71 billion, with the official record tying the thesis to medtech scale, portfolio reshaping, hospital demand, margin recovery, debt and cash conversion.
Financials and workspace tools are for paid members.
Paid login unlocks company financials, filing timeline, peer comparison, scorecard, and discussion. Valuation remains admin-only while we finalize market-data licensing.